Novel crystal forms of Entresto: a supramolecular complex of trisodium sacubitril/valsartan hemi-pentahydrate
- 20 September 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 24 (42) , 7387-7393
Abstract
The synthesis of Entresto, a multidrug cocrystal from sacubitril sodium and valsartan disodium using different conditions yielded six novel crystal forms. Stability studies showed higher stability of Form-I and III over the other crystal forms.Keywords
Funding Information
- Anusandhan National Research Foundation (CRG/2019/001388)
- Council of Scientific and Industrial Research, India (HCP0011)
This publication has 24 references indexed in Scilit:
- Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor–Neprilysin InhibitorClinical Pharmacokinetics, 2017
- Pharmaceutical cocrystals: walking the talkChemical Communications, 2016
- The Mechanism of Action of LCZ696Cardiac Failure Review, 2016
- Drug–Drug Molecular Salt Hydrate of an Anticancer Drug Gefitinib and a Loop Diuretic Drug Furosemide: An Alternative for Multidrug TreatmentJournal of Pharmaceutical Sciences, 2015
- Pharmaceutical cocrystals: along the path to improved medicinesChemical Communications, 2015
- Sacubitril/ValsartanHospital Pharmacy, 2015
- LCZ696: a dual-acting sodium supramolecular complexTetrahedron Letters, 2012
- Fixed dose drug combinations (FDCs): rational or irrational: a view pointBritish Journal of Clinical Pharmacology, 2008
- Pharmaceutical Cocrystals: An Emerging Approach to Physical Property EnhancementMRS Bulletin, 2006
- The trouble with making combination drugsNature Reviews Drug Discovery, 2006